Common Warts Epidemiology Forecast

• According to DelveInsight’s analysis, the total prevalent cases common warts  were approximately ~15,063,000 in the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
• The prevalence of common warts (verruca vulgaris) is estimated at approximately ~7–10% in the general population, with higher rates of ~10–20% in school-aged children, making it a frequent cutaneous viral infection.
• Incidence is strongly influenced by age and exposure settings, with significantly higher rates observed in children, adolescents, and individuals in communal environments (schools, sports facilities, dormitories) due to increased direct contact and fomite transmission.. 
• According to the secondary analysis, common warts are the most prevalent type, comprising nearly 70% of all warts seen in clinical practice, and because of their benign nature, they attract less clinical attention compared to other HPV-related conditions.

Common Warts Epidemiology Forecast in the 7MM

• 2025 Prevalent Cases of Common Warts : ~15,063,000
• 2036 Projected Prevalent Cases of Common Warts : ~XXX  
• Common Warts Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Common warts – Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Common warts, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Common Warts Understanding and Diagnosis Algorithm

Common Warts Overview 

Common warts (verruca vulgaris) are benign epidermal proliferations caused by human papillomavirus (HPV) infection, most commonly types 1, 2, 4, 27, and 57, entering through micro-abrasions in the skin. They present as rough, hyperkeratotic papules on the hands, fingers, periungual areas, and feet, often causing pain or cosmetic concern.

They are classified into common, plantar, flat, and periungual warts based on morphology and location. Transmission occurs via direct contact or fomites, making them highly contagious.Despite being benign and self-limiting, they show high recurrence due to persistent HPV infection and immune evasion, and are most prevalent in children, adolescents, and immunocompromised patients, contributing to a high global disease burden.

Further details are provided in the report.

Common Warts Diagnosis

Diagnosis of common warts (verruca vulgaris) is primarily clinical, based on characteristic appearance of rough, hyperkeratotic papules and typical distribution on the hands, fingers, periungual areas, and feet. A key clinical feature includes thrombosed capillaries (“black dots”) on dermoscopic or close examination.

In atypical, recurrent, or treatment-resistant cases, dermoscopy aids visualization of vascular patterns, while skin biopsy may be performed to exclude other lesions and confirm HPV-related pathology. Diagnosis is largely visual and non-invasive, and laboratory testing is rarely required.Accurate and early recognition is important to guide appropriate therapy selection and avoid unnecessary invasive procedures.

Further details are provided in the report.

Common Warts Epidemiology

Key Findings from Common Warts Epidemiological Analysis and Forecast 

• According to DelveInsight’s estimates, in 2025, the total number of prevalent cases of common warts in the 7MM were ~15,063,000. 
• The highest burden is observed in children and adolescents, while immunocompromised individuals also show significantly increased incidence and persistence rates.
• HPV infections causing cutaneous warts are most commonly linked to low-risk types 1, 2, 4, 27, and 57, which account for the majority of common wart cases. 
• In Europe, warts were identified as the most common skin disease, with a prevalence of 41.3%, highlighting their significant burden on dermatological health in the region.
• Plantar warts account for a significant proportion of cases in clinical settings, as they are more likely to become symptomatic due to pressure and pain on weight-bearing surfaces. 
• Despite being benign, common warts show a high spontaneous resolution rate (within 1–2 years in many cases), but a substantial proportion persist or recur due to immune evasion by HPV. 
• As per the secondary analysis, warts are a common condition worldwide, affecting about 10% of the population, with prevalence rising to 10–20% in school-aged children; they are rare in infancy and early childhood, increase during school years, peak between 12 and 16 years, and are more frequently observed in immunosuppressed individuals and meat handlers.

Scope of the Common Warts Market Report

• The Common Warts Market report covers a segment of a descriptive overview of common warts, explaining their causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression. 

Common Warts Market Report Insights

Common Warts Patient Population Forecast

Common Warts Market Report Key Strengths

• Epidemiology‑based (Epi‑based) Bottom‑up Forecasting
• 11-year Forecast 
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of common warts? What will be the growth opportunities across the 7MM concerning the patient population with common warts?
• What is the historical and forecasted common warts patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy the Common Warts Market Forecast Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.